945 related articles for article (PubMed ID: 33008459)
1. Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis.
Ahmed Z
Hum Genomics; 2020 Oct; 14(1):35. PubMed ID: 33008459
[TBL] [Abstract][Full Text] [Related]
2. Multi-omics strategies for personalized and predictive medicine: past, current, and future translational opportunities.
Ahmed Z
Emerg Top Life Sci; 2022 Apr; 6(2):215-225. PubMed ID: 35234253
[TBL] [Abstract][Full Text] [Related]
3. Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis.
Ahmed Z
Prog Mol Biol Transl Sci; 2022; 190(1):101-125. PubMed ID: 36007996
[TBL] [Abstract][Full Text] [Related]
4. The future is now? Clinical and translational aspects of "Omics" technologies.
D'Adamo GL; Widdop JT; Giles EM
Immunol Cell Biol; 2021 Feb; 99(2):168-176. PubMed ID: 32924178
[TBL] [Abstract][Full Text] [Related]
5. Unveiling the future of metabolic medicine: omics technologies driving personalized solutions for precision treatment of metabolic disorders.
Singh S; Sarma DK; Verma V; Nagpal R; Kumar M
Biochem Biophys Res Commun; 2023 Nov; 682():1-20. PubMed ID: 37788525
[TBL] [Abstract][Full Text] [Related]
6. Artificial intelligence with multi-functional machine learning platform development for better healthcare and precision medicine.
Ahmed Z; Mohamed K; Zeeshan S; Dong X
Database (Oxford); 2020 Jan; 2020():. PubMed ID: 32185396
[TBL] [Abstract][Full Text] [Related]
7. Power of proteomics and progress in precision medicine - 13th central and eastern European proteomic conference (CEEPC), Ustroń, Poland.
Gadher SJ; Widlak P; Kovarova H
Expert Rev Proteomics; 2020 May; 17(5):335-340. PubMed ID: 32510255
[TBL] [Abstract][Full Text] [Related]
8. Rise of Deep Learning for Genomic, Proteomic, and Metabolomic Data Integration in Precision Medicine.
Grapov D; Fahrmann J; Wanichthanarak K; Khoomrung S
OMICS; 2018 Oct; 22(10):630-636. PubMed ID: 30124358
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
[TBL] [Abstract][Full Text] [Related]
10. [OMICS AND BIG DATA, MAJOR ADVANCES TOWARDS PERSONALIZED MEDICINE OF THE FUTURE?].
Scheen AJ
Rev Med Liege; 2015; 70(5-6):262-8. PubMed ID: 26285450
[TBL] [Abstract][Full Text] [Related]
11. A Multi-Omics Perspective of Quantitative Trait Loci in Precision Medicine.
Ye Y; Zhang Z; Liu Y; Diao L; Han L
Trends Genet; 2020 May; 36(5):318-336. PubMed ID: 32294413
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.
Lococo F; Boldrini L; Diepriye CD; Evangelista J; Nero C; Flamini S; Minucci A; De Paolis E; Vita E; Cesario A; Annunziata S; Calcagni ML; Chiappetta M; Cancellieri A; Larici AR; Cicchetti G; Troost EGC; Ádány R; Farré N; Öztürk E; Van Doorne D; Leoncini F; Urbani A; Trisolini R; Bria E; Giordano A; Rindi G; Sala E; Tortora G; Valentini V; Boccia S; Margaritora S; Scambia G
BMC Cancer; 2023 Jun; 23(1):540. PubMed ID: 37312079
[TBL] [Abstract][Full Text] [Related]
13. Are innovation and new technologies in precision medicine paving a new era in patients centric care?
Seyhan AA; Carini C
J Transl Med; 2019 Apr; 17(1):114. PubMed ID: 30953518
[TBL] [Abstract][Full Text] [Related]
14. 'Omics Approaches in Breast Cancer Research and Clinical Practice.
Kalita-de Croft P; Al-Ejeh F; McCart Reed AE; Saunus JM; Lakhani SR
Adv Anat Pathol; 2016 Nov; 23(6):356-367. PubMed ID: 27740960
[TBL] [Abstract][Full Text] [Related]
15. Machine learning and network medicine: a novel approach for precision medicine and personalized therapy in cardiomyopathies.
Infante T; Francone M; De Rimini ML; Cavaliere C; Canonico R; Catalano C; Napoli C
J Cardiovasc Med (Hagerstown); 2021 Jun; 22(6):429-440. PubMed ID: 32890235
[TBL] [Abstract][Full Text] [Related]
16. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
Tebani A; Afonso C; Marret S; Bekri S
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
[TBL] [Abstract][Full Text] [Related]
17. Status and perspectives of biomarker validation for diagnosis, stratification, and treatment.
Skov J; Kristiansen K; Jespersen J; Olesen P
Public Health; 2021 Jan; 190():173-175. PubMed ID: 33309006
[TBL] [Abstract][Full Text] [Related]
18. Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.
Ogino S; Nishihara R; VanderWeele TJ; Wang M; Nishi A; Lochhead P; Qian ZR; Zhang X; Wu K; Nan H; Yoshida K; Milner DA; Chan AT; Field AE; Camargo CA; Williams MA; Giovannucci EL
Epidemiology; 2016 Jul; 27(4):602-11. PubMed ID: 26928707
[TBL] [Abstract][Full Text] [Related]
19. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
